ArticleCancer immunology research2021

Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8

Chang-Yu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.